Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,280Revenue $M85.6Net Margin (%)-74.7Z-Score10.8
Enterprise Value $M3,317EPS $-1.9Operating Margin %-62.3F-Score5
P/E(ttm))0Cash Flow Per Share $-2.0Pre-tax Margin (%)-75.2Higher ROA y-yY
Price/Book86.910-y EBITDA Growth Rate %0Quick Ratio0.7Cash flow > EarningsY
Price/Sales27.75-y EBITDA Growth Rate %-62.2Current Ratio0.8Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-37.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-154.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M35.7ROI % (ttm)-53.4Gross Margin Increase y-yY

Gurus Latest Trades with PCRX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
PCRXMariko Gordon 2014-03-31 Add0.19%$55.83 - $80.43
$ 9236%Add 5.13%1,371,042
PCRXRon Baron 2014-03-31 Add$55.83 - $80.43
$ 9236%Add 163.28%17,100
PCRXMariko Gordon 2013-12-31 Add2.08%$47.74 - $56.97
$ 9275%Add 203.52%1,304,190
PCRXRon Baron 2013-12-31 Buy $47.74 - $56.97
$ 9275%New holding, 6495 sh.6,495
PCRXMariko Gordon 2013-09-30 Add0.93%$30.01 - $47.47
$ 92153%Add 3812.66%429,688
PCRXMariko Gordon 2013-06-30 Buy 0.02%$25.84 - $30.26
$ 92218%New holding, 10982 sh.10,982
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PCRX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PCRX Ron Baron 2014-03-3117,1000.050+163.28%
PCRX Mariko Gordon 2014-03-311,371,0423.843.8+5.13%
Premium Most recent portfolio changes are included for Premium Members only!

PCRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
STACK DAVID MPresident, CEO and Chairman 2014-07-15Sell15,000$86.751.24view
PATOU GARYChief Medical Officer 2014-07-14Sell29,700$86.961view
HASTINGS PAUL JDirector 2014-07-10Sell2,500$84.414.05view
LONGENECKER JOHN P PHDDirector 2014-06-30Sell1,000$91.6-4.12view
Wicki AndreasDirector 2014-06-09Sell68,000$85.432.81view
Wicki AndreasDirector 2014-06-06Sell67,900$82.626.31view
Wicki AndreasDirector 2014-06-03Sell68,000$80.698.85view
Wicki AndreasDirector 2014-05-27Sell64,400$77.9312.7view
Wicki AndreasDirector 2014-05-21Sell3,600$77.812.89view
PATOU GARYChief Medical Officer 2014-05-12Sell30,000$74.3918.07view

Press Releases about PCRX :

Quarterly/Annual Reports about PCRX:

News about PCRX:

Articles On GuruFocus.com
Mariko Gordon's First Quarter Top Five May 15 2014 
Baron Funds Comments on Pacira Pharmaceuticals Mar 05 2014 
comment on PCRX Mar 15 2013 
Weekly CFO Buys Highlight: PCRX, UGI, MIG, GLT, IOSP Feb 27 2011 
Weekly CFO Buys Highlight: REFR, UGI, PCRX, NOIZ Feb 21 2011 
Pacira Pharmaceuticals Inc. (PCRX) CFO James S Scibetta buys 5,000 Shares Feb 16 2011 
Pacira Pharmaceuticals Inc. (PCRX) CEO David M Stack buys 5,000 Shares Feb 11 2011 

More From Other Websites
UPDATE: Bank Of America Reiterates On Pacira Pharmaceuticals On Positive Survey Results Jul 17 2014
Pacira Pharmaceuticals Announces Timing for Second Quarter 2014 Financial Results Webcast and... Jul 17 2014
Pacira Pharmaceuticals Announces Timing for Second Quarter 2014 Financial Results Webcast and... Jul 17 2014
Pacira's Exparel Positive in Phase IV Studies Jun 27 2014
Coverage initiated on Pacira Pharma by Canaccord Genuity Jun 27 2014
Pacira Pharmaceuticals (PCRX) Reaches New Lifetime High Today Jun 19 2014
UPDATE: JMP Securities Initiates Coverage On Pacira Pharmaceuticals Jun 17 2014
With concentrated bets, tiny U.S. mutual funds jump up rankings Jun 11 2014
Why Pacira's Rise Is Far From Over Jun 11 2014
PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... Jun 04 2014
Pacira Pharmaceuticals, Inc. to Present at June Investor Conferences May 27 2014
Nasdaq stocks posting largest percentage increases May 20 2014
Cyclical stocks test a growth speculator's mettle May 13 2014
Insider Trading Alert - ENS, HOS And PCRX Traded By Insiders May 13 2014
Pacira Pharmaceuticals: 4 Different Insiders Have Sold Shares This Month May 11 2014
Pacira Pharmaceuticals, Inc. Announces sNDA Submission for EXPAREL Nerve Block Indication May 07 2014
Wider-than-Expected Loss at Pacira, Revs Up May 06 2014
[video] Three Stock Picks From Daruma Founder Mariko Gordon May 05 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
Email Hide